The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Developing Drugs To Prevent Prostate Cancer Spread.
Funder
National Health and Medical Research Council
Funding Amount
$99,248.00
Summary
Current therapies for prostate cancer lose their efficacy as the cancer advances. Moreover, despite the spread of cancer being the major cause of prostate cancer mortality, there is no therapy available which selectively targets this process, thus new agents are needed. By using computer modelling to predict molecules that bind to the cell surface protein CD151 and testing these in biological assays, we aim to discover molecules that reduce cell migration of prostate cancer and that can be devel ....Current therapies for prostate cancer lose their efficacy as the cancer advances. Moreover, despite the spread of cancer being the major cause of prostate cancer mortality, there is no therapy available which selectively targets this process, thus new agents are needed. By using computer modelling to predict molecules that bind to the cell surface protein CD151 and testing these in biological assays, we aim to discover molecules that reduce cell migration of prostate cancer and that can be developed into anti-migration drugs.Read moreRead less
Cancer disparities exist between rural and metropolitan patients. Inferior survival outcomes are reported for rural residents, which can amount to a 7% difference in 5-year survival proportions. Factors implicated include: socio-economic disadvantage, limited access to specialist services, later diagnosis, and poorer treatment. Little is known about the decision-making process of patients. This research project examines patients’ preferences for cancer treatment, and whether there are difference ....Cancer disparities exist between rural and metropolitan patients. Inferior survival outcomes are reported for rural residents, which can amount to a 7% difference in 5-year survival proportions. Factors implicated include: socio-economic disadvantage, limited access to specialist services, later diagnosis, and poorer treatment. Little is known about the decision-making process of patients. This research project examines patients’ preferences for cancer treatment, and whether there are differences depending on geographical location.Read moreRead less
Understanding Influenza-specific T Cell Immunity In The Indigenous And Non-Indigenous Populations
Funder
National Health and Medical Research Council
Funding Amount
$49,202.00
Summary
Hospitalisation and mortality rates from influenza are high in the Indigenous population. There is an urgent need for one-shot universal vaccine that protects against seasonal and pandemic strains. To identify potential vaccine targets we firstly have to determine which viral proteins will induce a large protective immune response. These responses vary between ethnicities thus comparisons will be drawn between Indigenous and non-Indigenous Australians to determine multiple vaccine candidates tha ....Hospitalisation and mortality rates from influenza are high in the Indigenous population. There is an urgent need for one-shot universal vaccine that protects against seasonal and pandemic strains. To identify potential vaccine targets we firstly have to determine which viral proteins will induce a large protective immune response. These responses vary between ethnicities thus comparisons will be drawn between Indigenous and non-Indigenous Australians to determine multiple vaccine candidates that will be protective across ethnicities.Read moreRead less